Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
European Psychiatry : the Journal of the Association of European Psychiatrists|June 28, 2008
Agomelatine: a novel mechanism of antidepressant action involving the melatonergic and the serotonergic systemLuis San, Belen ArranzEuropean Addiction Research|September 14, 2007
Antipsychotic drug treatment of schizophrenic patients with substance abuse disordersLuis San, Belen Arranz, Jose Martinez-RagaPharmacogenetics and Genomics|May 3, 2005
Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosisLucy A Templeman, Gavin P Reynolds, Belen Arranz, et al.The American Journal of Psychiatry|October 3, 2006
Effect of 5-HT1A receptor gene polymorphism on negative and depressive symptom response to antipsychotic treatment of drug-naive psychotic patientsGavin P Reynolds, Belen Arranz, Lucy A Templeman, et al.The Journal of Nervous and Mental Disease|May 21, 2013
Factors predicting hostility in outpatients with schizophrenia: 36-month results from the SOHO studySusana Ochoa, David Suarez, Diego Novick, et al.The International Journal of Neuropsychopharmacology|December 15, 2012
The obesity risk gene FTO influences body mass in chronic schizophrenia but not initial antipsychotic drug-induced weight gain in first-episode patientsGavin P Reynolds, Olga O Yevtushenko, Sarah Gordon, et al.Psychiatry Research|September 8, 2012
One-year, randomized, open trial comparing olanzapine, quetiapine, risperidone and ziprasidone effectiveness in antipsychotic-naive patients with a first-episode psychosisLuis San, Belen Arranz, Victor Perez, et al.Psychiatry Research|November 20, 2009
Predictors of schizophrenia in patients with a first episode of psychosisNicolas Ramirez, Belen Arranz, Jose Salavert, et al.Journal of Dual Diagnosis|October 30, 2015
Substance Use in Patients With First-Episode Psychosis: Is Gender Relevant?Belen Arranz, Gemma Safont, Iluminada Corripio, et al.Pageof 3